Biotechnological interventions in Withania somnifera (L.) Dunal

作者: Pritika Singh , Rupam Guleri , Varinder Singh , Gurpreet Kaur , Hardeep Kataria

DOI: 10.1080/02648725.2015.1020467

关键词:

摘要: Withania somnifera is one of the most valued plants and extensively used in Indian, Unani, African systems traditional medicine. It possess a wide array therapeutic properties including anti-arthritic, anti-aging, anti-cancer, anti-inflammatory, immunoregulatory, chemoprotective, cardioprotective, recovery from neurodegenerative disorders. With growing realization benefits associated challenges improvement W. somnifera, studies on exploration genetic chemotypic variations, identification characterization important genes, understanding secondary metabolites production their modulation has gained significant momentum. In recent years, several vitro vivo preclinical have facilitated validation potential phytochemicals derived provided necessary impetus for gaining deeper insight into mechanistic aspects involved mode action these pharmaceutically active constituents. The present review highlights some current developments future prospects biotechnological intervention this medicinal plant.

参考文章(89)
Abhinav Grover, Shashank Prakash Katiyar, Jeyaraman Jeyakanthan, Vikash Kumar Dubey, Durai Sundar, Blocking Protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera BMC Genomics. ,vol. 13, pp. 1- 11 ,(2012) , 10.1186/1471-2164-13-S7-S20
O. P. Sidhu, Sanjay Annarao, Sandipan Chatterjee, Rakesh Tuli, Raja Roy, C. L. Khetrapal, Metabolic alterations of Withania somnifera (L.) dunal fruits at different developmental stages by NMR spectroscopy. Phytochemical Analysis. ,vol. 22, pp. 492- 502 ,(2011) , 10.1002/PCA.1307
Ram Harsh Singh, K. Narsimhamurthy, Girish Singh, Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. ,vol. 9, pp. 369- 374 ,(2008) , 10.1007/S10522-008-9185-Z
Camille G. Wermuth, Multitargeted drugs: the end of the "one-target-one-disease" philosophy? Drug Discovery Today. ,vol. 9, pp. 826- 827 ,(2004) , 10.1016/S1359-6446(04)03213-1
M Wanke, K Skorupinska-Tudek, E Swiezewska, Isoprenoid biosynthesis via 1-deoxy-D-xylulose 5-phosphate/2-C-methyl-D-erythritol 4-phosphate (DOXP/MEP) pathway. Acta Biochimica Polonica. ,vol. 48, pp. 663- 672 ,(2001) , 10.18388/ABP.2001_3901
Swagata Ray, Biswajit Ghosh, Sucharita Sen, Sumita Jha, Withanolide production by root cultures of Withania somnifera transformed with Agrobacterium rhizogenes. Planta Medica. ,vol. 62, pp. 571- 573 ,(1996) , 10.1055/S-2006-957977
Arpita Konar, Navjot Shah, Rumani Singh, Nishant Saxena, Sunil C. Kaul, Renu Wadhwa, Mahendra K. Thakur, Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0027265
Arun Kumar, Bilal A. Mir, Deepmala Sehgal, Tanvir H. Dar, Sushma Koul, Maharaj K. Kaul, Soom N. Raina, Ghulam N. Qazi, Utility of a multidisciplinary approach for genome diagnostics of cultivated and wild germplasm resources of medicinal Withania somnifera , and the status of new species, W. ashwagandha , in the cultivated taxon Plant Systematics and Evolution. ,vol. 291, pp. 141- 151 ,(2011) , 10.1007/S00606-010-0372-4
Chihiro Tohda, Tomoharu Kuboyama, Katsuko Komatsu, Search for Natural Products Related to Regeneration of the Neuronal Network Neurosignals. ,vol. 14, pp. 34- 45 ,(2005) , 10.1159/000085384
Somesh Singh, Rishi. K. Vishwakarma, R. J. Santosh Kumar, Prashant D. Sonawane, Ruby, Bashir M. Khan, Functional characterization of a flavonoid glycosyltransferase gene from Withania somnifera (Ashwagandha). Applied Biochemistry and Biotechnology. ,vol. 170, pp. 729- 741 ,(2013) , 10.1007/S12010-013-0230-2